MedTech Huma has completed a Series D round of financing amounting to around £62 million.
The London scaleup connects medics with patients and is driving what it calls a ‘leap from reactive to proactive medicine’.
It has also launched a cloud platform with generative AI integrations which it says will reduce the process of launching a digital health product that meets regulatory demands down from years to days.
The platform offers ‘no code’ configuration of regulated disease management tools for any therapeutic area, a library of pre-built modules and device connectivity capabilities, a cloud-agnostic framework for flexible hosting, readily available APIs and integration capabilities, the ability to host and deploy diagnostic and predictive AI algorithms, plus a marketplace to advance digital-first care and research.
The round created a total issuance of shares by Huma of over $80m, taking its funding to date to more than $300m.
New and existing strategic and financial investors participated, including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures and Leaps by Bayer and others. HSBC Bank plc acted as advisor to Huma during the fundraise.
“We have known Huma for several years and we’ve been impressed by their remarkable progress,” said Dr Juergen Eckhardt, EVP, head of leaps by Bayer and pharmaceuticals business, development & licensing.
“We have seen this first-hand. They have demonstrated strong growth and excellent metrics. With their next-generation AI capabilities and Huma Cloud Platform, Huma can partner with pharma companies to deliver efficient digital health solutions to patients focused on predictive and proactive care.”
To date, Huma’s technology has powered projects in over 3,000 hospitals and clinics. The platform has been used to engage and screen over 35m individuals, with 1.8m active users across its products in over 70 countries.
Huma also collaborates with over half of the top 20 pharmaceutical companies globally and has been involved in major national healthcare projects worldwide.
Dan Vahdat, founder and CEO of Huma, said: “I am thankful for the support of our new and existing shareholders, helping our vision become a reality, which we are closer to than ever before.
“We are here to accelerate the adoption of digital and AI across care and research, and we do that by making the building of digital health solutions for care and research easy. We like to think of Huma Cloud Platform much like Shopify but for digital health instead of eCommerce.
“We believe when digital and AI are scaled, they become affordable for both the poor and the rich. They remain consistent and will help us transition medicine from being reactive to proactive.”